About Particella
Particella, Inc. (formerly DNAlite Therapeutics) is a preclinical biotechnology company that has developed an oral lipid nanoparticle technology to deliver nucleic acids to the intestinal epithelium.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Venture Round
Global Headquarters
Undisclosed
Tracked Since
Oct 11, 2026
Web & Domain Identity
Official Website
particella.bio
Domain Registered Date
Apr 14, 2023
Social & Network Presence
X / Twitter Profile
Not linked
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Milestone
Website domain registered
particella.bio
Investors & Backers
IndieBio
Funding History
Venture Round
· Undisclosed
Backers: IndieBio
Undisclosed Source
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allVitalls
vitalls.ai
Seed Abu Dhabi, United Arab Emirates · Oct 2026
Hexagon Bio
hexagonbio.com
Series-B+ Oct 2026
RefloDx
reflodx.com
Seed Kaysville, United States · Oct 2026
HeyVoli
heyvoli.com
Pre-Seed Bangalore, India · Oct 2026
CureBay
curebay.com
Series-B+ Bhubaneshwar, India · Oct 2026
4Tissue
4tissue.com
Series-A Ghent, Belgium · Oct 2026